Publications by authors named "Simona Maria Di Modica"

Claim this Profile
B
Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin-receptor ligand trap RAP-536 in β-thalassemic mice.
Emanuele Tanzi, Simona Maria Di Modica, Jessica Bordini, Violante Olivari, Alessia Pagani

Am J Hematol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular and animal models for the investigation of β-thalassemia.
Antonella Nai, Celia Cordero-Sanchez, Emanuele Tanzi, Alessia Pagani, Laura Silvestri, Simona Maria Di Modica

Blood Cells Mol Dis· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single approach to targeting transferrin receptor 2 corrects iron and erythropoietic defects in murine models of anemia of inflammation and chronic kidney disease.
Violante Olivari, Simona Maria Di Modica, Maria Rosa Lidonnici, Mariam Aghajan, Celia Cordero-Sanchez

Kidney Int· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent β-thalassemia.
Simona Maria Di Modica, Emanuele Tanzi, Violante Olivari, Maria Rosa Lidonnici, Mariateresa Pettinato

Am J Hematol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correcting β-thalassemia by combined therapies that restrict iron and modulate erythropoietin activity.
Carla Casu, Mariateresa Pettinato, Alison Liu, Mariam Aghajan, Vania Lo Presti, Simona Maria Di Modica

Blood· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis